• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 28, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Mason researchers Narayanan and Veneziano receive funding to build better vaccines

Bioengineer by Bioengineer
January 21, 2020
in Health
Reading Time: 1 min read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: George Mason University


George Mason University’s Aarthi Narayanan, Associate Professor, College of Science and the National Center for Biodefense and Infectious Disease, and Remi Veneziano, Assistant Professor, Volgenau School of Engineering, received $314,000 from U.S. Army Medical Research Acquisition Activity (USAMRAA) for a project researching DNA-nanoparticles and vaccine design.

This project will explore a new vaccine design that uses one-, two-, and three-dimensional structures made out of DNA molecules, commonly referred to as DNA origami, to deliver viral antigens. The benefit of this approach over traditional vaccines lies in the customizable, nanoscale organization of the DNA structures. Antigens can be placed in precise locations on the DNA scaffold, and the antigens delivered can be heterogenous/combinations. The researchers expect to find that the specificity of arrangement increases the immunogenic potential of the vaccine while ensuring safety.

The vaccine design being investigated could pave the way for a uniform approach to serious challenges, such as dengue virus and other emerging infectious agents. Following a proven approach to develop a vaccine would help it be more readily accepted by the market and decrease the time it takes to get a vaccine to patients.

###

Media Contact
George Mason University
[email protected]
703-993-7073

Tags: BiochemistryBiologyBiotechnologyGrants/FundingImmunology/Allergies/AsthmaInfectious/Emerging DiseasesMedicine/HealthVaccinesVirology
Share12Tweet8Share2ShareShareShare2

Related Posts

Trunk Control May Hold a Key to Balance and Fall Risk in Older Adults

September 27, 2026

AI Tells Doctors When It Is Unsure About Cancer Treatment Success

September 27, 2026

When Autism Diagnoses Fade: Early Intervention and Milder Symptoms Mark Children Who Lose the Label

September 27, 2026

Weight-Loss Drugs Are Redrawing the Map of Sleep Medicine

September 27, 2026
Please login to join discussion

POPULAR NEWS

  • Trunk Control May Hold a Key to Balance and Fall Risk in Older Adults

    29 shares
    Share 12 Tweet 7
  • AI Tells Doctors When It Is Unsure About Cancer Treatment Success

    29 shares
    Share 12 Tweet 7
  • Engineered mini CRISPR enzyme gets a 60-fold power boost for gene editing

    29 shares
    Share 12 Tweet 7
  • When Autism Diagnoses Fade: Early Intervention and Milder Symptoms Mark Children Who Lose the Label

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Trunk Control May Hold a Key to Balance and Fall Risk in Older Adults

AI Tells Doctors When It Is Unsure About Cancer Treatment Success

Engineered mini CRISPR enzyme gets a 60-fold power boost for gene editing

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.